| abstract |
The invention relates to the use of thiol compounds in viral inactivation in a cell-free environment, especially in the blood, blood plasma, blood serum, conserved blood, blood products, cell culture liquids and nutrient media and to the application of said compounds on the surface of plants and animals. Viral inactivation occurs without requiring cell metabolism. The preferred thiol compounds are cysteine and its derivatives, mercaptoalkanol, dithiocarbamate, thiophenol and 2-mercaptoethane-sulfonic acid. |